microRNA 4675 (MIR4675)

microRNA 4675 (MIR4675) is a member of the human microRNA (miRNA) family, which consists of short (~22 nucleotide), non-coding RNA molecules that regulate gene expression at the post-transcriptional level[1][3]. miRNAs are processed from longer precursors and incorporated into the RNA-induced silencing complex (RISC), where they bind complementary sequences in the 3' untranslated region (UTR) of target mRNAs[1][2]. This leads to translational repression or mRNA degradation, thereby fine-tuning protein levels in the cell. While specific biological functions or disease associations for MIR4675 have not been established, miRNAs are known to play roles in cellular development, differentiation, metabolism, proliferation, migration, and apoptosis[1][2]. Dysregulation of miRNAs can contribute to pathologies such as cancer, immune disorders, and developmental abnormalities[5]. Some miRNAs also have potential as biomarkers due to their stability in body fluids like blood[1]. However, there is currently no evidence that MIR4675 itself is used as a therapeutic target, diagnostic biomarker, or drug target, nor are there known safety or efficacy data specific to MIR4675. If detailed, structured, or disease-specific information about MIR4675 becomes available in future research, this summary should be updated accordingly.

Other names

hsa-mir-4675MIR4675